Vivos Therapeutics
Littleton
About Vivos Therapeutics
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including mild to moderate obstructive sleep apnea (OSA). Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective alternative for people with mild-to-moderate OSA. Combining technologies and protocols that can alter the size, shape and position of the tissues of the upper human airway, the Vivos System opens airway space and can significantly reduce symptoms and conditions associated with mild-to-moderate OSA. Vivos Therapeutics was established on January 1, 2013 by Dave Singh and R. Kirk Huntsman in Littleton, Colorado.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $59.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2026)
- Ticker: nasdaq:VVOS
- Website: vivos.com
- Phone: (844)-672-4357
Industries & Categories
Dental, Health Care, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/vivos-therapeutics-124422 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.